the most common recurrent copy-number variants associated with autism, developmental delay and epilepsy are flanked by segmental duplications. complete genetic characterization of these events is challenging because their breakpoints often occur within high-identity, copy-number polymorphic paralogous sequences that cannot be specifically assayed using hybridization-based methods. Here we provide a protocol for breakpoint resolution with sequence-level precision. Massively parallel sequencing is performed on libraries generated from haplotype-resolved chromosomes, genomic Dna or molecular inversion probe (MIp)-captured breakpoint-informative regions harboring paralog-distinguishing variants. Quantification of sequencing depth over informative sites enables breakpoint localization, typically within several kilobases to tens of kilobases. Depending on the approach used, the sequencing platform, and the accuracy and completeness of the reference genome sequence, this protocol takes from a few days to several months to complete. once established for a specific genomic disorder, it is possible to process thousands of Dna samples within as little as 3-4 weeks. protocol for resolving breakpoints including a series of experimental approaches (Fig. 1) , and we provide general guidelines for its successful application to particular cases of interest. Although hybridizationbased approaches are still the primary method by which copy-number variants are discovered, we focus mainly on two massively parallel sequencing strategiesanalysis of WGS data and targeted capture and sequencing of informative regions using MIPs-as they provide the greatest potential for breakpoint resolution within duplicated sequence. More detailed protocols for the other methodologies outlined here have been previously published 15, 16 .
IntroDuctIon
Several regions of the human genome are predisposed to recurrent duplication and deletion 1 . Nonallelic homologous recombination (NAHR) between directly oriented segmental duplications, defined as contiguous sequences at least 1 kb in length having at least 90% identity, results in recurrent gain and loss of the intervening sequence 2, 3 . Collectively, such events affect hundreds of genes and have been associated with many diseases, including autism, schizophrenia, intellectual disability, epilepsy, macrocephaly, microcephaly, congenital defects and severe obesity, among others 4 .
Although a variety of technologies reliably detect recurrent duplications and deletions, determining the breakpoints within duplicated sequences remains a significant challenge. Pulsed-field gel electrophoresis followed by genomic Southern blots was originally used to map breakpoints in patients with Charcot-Marie-Tooth disease type 1A having a duplication at 17p12 (ref. 5) . This method required the preparation of highmolecular-weight DNA, an often trial-and-error identification of informative restriction enzymes, and the design of probes adjacent to the breakpoints themselves. When array comparative genomic hybridization (array CGH) methods 6 became the standard for copy-number variant detection, they were often applied for the initial refinement of breakpoints 7, 8 ; follow-up with long-range PCR, subcloning and capillary sequencing in some cases then enabled the precise delineation of breakpoints 8 . This strategy worked well for breakpoints mapping in unique regions of the genome and would, in principle, prove effective in mapping breakpoints within small segmental duplications (<10 kb). However, it cannot be successfully applied to most recurrent, NAHR-mediated microdeletions and duplications, whose breakpoints map to the largest and most highly identical segmental duplications. In these cases, refinement by array CGH is of limited utility because of probe cross-hybridization. As a result, the researcher can only narrow the breakpoints to within hundreds of kilobases of nearly identical duplicated sequence. Thus, subcloning and sequencing several long-range PCR products across these large duplicated regions would be required for breakpoint resolution-a particularly difficult proposition, given the generation of nonspecific PCR products.
More recent bioinformatics approaches involving the analysis of split-read or read-pair sequence signatures from massively parallel whole-genome sequencing (WGS) data 9, 10 are not reliable in these regions. These methods depend on the sequence read or the read-pair itself traversing the junction formed via NAHR. However, short read lengths, short library insert sizes and the paucity of distinguishing variants within breakpoint-containing segmental duplications make detection of a junction-spanning sequence read or read-pair highly unlikely. Finally, breakpoint resolution is often confounded by copy-number polymorphisms, gaps in the reference genome and alternative structural haplotypes affecting breakpoint regions 11, 12 . Incomplete knowledge of the sequence, structure and genetic variation at these loci presents a substantial barrier to breakpoint localization regardless of the method used.
Despite its difficulty, accurate breakpoint resolution is crucial for understanding the origins and consequences of recurrent duplications and deletions. Obtaining breakpoint data from multiple independent events may elucidate factors influencing NAHR susceptibility and may help identify potential hotspots. It is becoming apparent, for example, that specific structural configurations within the genome increase susceptibility to some genomic disorders, whereas others are protective with respect to recurrent rearrangements 12, 13 . Furthermore, precise breakpoint mapping will reveal the effects of recurrent rearrangements on genes within breakpoint regions. Most such genes have hardly been characterized, and their disruption may contribute to both disease phenotypes and phenotypic variability associated with some genomic disorders 14 . Here we detail a approach has been used to genotype paralog-specific copy number, to discover structural variation, to detect interlocus gene conversion and to assay paralog-specific gene expression. Although these studies were conducted on human DNA, the method should prove similarly useful, in principle, for large duplicated regions in the genome of any organism. Whether or not sequencing data can be used for any of the mentioned purposes, however, depends on the identification of SUNs. Because the level of attainable breakpoint resolution is determined by these markers, careful analysis of their density and spatial distribution should always serve as an initial step to assess whether using a sequencing approach described here makes sense for a particular case. To that end, we provide tables including the number of 30-bp SUN k-mers (SUNKs) 22 in different-sized windows (1, 5, 10, 25 and 50 kb) across the GRCh37 reference genome (http://eichlerlab.gs.washington.edu/ breakpoint_protocol_supplementary_data).
Having an accurate genome sequence and understanding haplotypic and copy-number variations are crucial foundations upon which all subsequent steps depend (Box 1). Sequences corresponding to breakpoint regions are frequently misassembled, even in the finished human reference genome, and they often contain gaps due to the high sequence identity and highly duplicated nature of sequences therein [24] [25] [26] . Furthermore, such sequences are enriched for copy-number polymorphisms and structural variation. All these factors complicate SUN identification and warrant Figure 1 | General workflow for breakpoint resolution. The diagram outlines the typical stages involved in sequence-based breakpoint resolution and indicates some relevant associated experiments and computational analyses. Optional subsections of the procedure described briefly in this protocol are highlighted in yellow, whereas strategies for attaining sequence-level breakpoint resolution covered in more detail are highlighted in green. Targeted array CGH is displayed near the top of the figure because until recently it was the method of choice for breakpoint resolution after CNV detection-the sequencing-based approaches were only developed within the past few years. Today, however, sequencing approaches are sensible starting points for breakpoint resolution. Note that, depending on the particular region of interest, further genomic characterization of the region may be crucial to successfully refining breakpoint locations (see Box 1 for discussion). Genomic characterization is often an iterative process (circular arrow), and because it facilitates data interpretation for all breakpoint resolution methods it is included in the diagram near the center. CNV, copy-number variant.
careful consideration before proceeding to study a particular microdeletion or microduplication using this protocol. In general, the more nearly identical and the higher the total copy of breakpointassociated segmental duplications, the more difficult breakpoint resolution becomes. The number of SUNs decreases as sequence identity increases, and accurate copy-number prediction grows more challenging as the number of homologous sequences increases. Biological factors can sometimes simplify the procedure. For example, the patients with the 17q21.31 microdeletion syndrome included in our study were all heterozygous for the haplotype on which the microdeletions occurred. As a result, breakpoint resolution amounted to assessing the presence or absence of haplotype-specific SUNs in WGS data 14 , a straightforward task compared with inferring deleted regions from a decrease in read-depth over SUNs, which would be necessary if an individual were homozygous for a single haplotype. As a second example, RHD deletion and duplication breakpoints were readily refined 23 because the breakpoint-containing paralogs are not present at high total copy number at many locations throughout the genome. Other biological factors, particularly frequent interlocus gene conversion between associated segmental duplications, sometimes complicate accurate breakpoint localization.
As noted above, the precision of breakpoint resolution for recurrent duplications and deletions is inherently limited by the number and spatial distribution of distinguishing variants within associated segmental duplications, and it depends upon where the breaks occur relative to these variants. Breakpoints occurring at different locations within long stretches of identical sequence Figure 3 | Resolution of 17q21.31 microdeletion breakpoints using WGS data. (a,b) Read-depth (vertical lines) at breakpoint-informative paralogous sequence variants (PSVs, dots) is shown over an alignment of the paralogous segmental duplications mediating the microdeletion for the patient's mother (a), who lacks the microdeletion, and for the patient (b). Structural haplotypes for both chromosomes for each individual are given in parentheses. Variation in read-depth between informative variants occurs even in the absence of any copy-number variation at these loci. However, because the patient is heterozygous for the deletion-bearing haplotype, a read-depth of zero at informative variants is observed over deleted regions, allowing the breakpoint to be unambiguously refined to an ~22-kb window (between dashed lines). Note that a region of sequence (red line) of ~70 kb in size was missing from the reference genome, and it had to be resolved before sequencing data could be accurately interpreted (Box 1). between associated segmental duplications will be indistinguishable, as deletion or duplication products of NAHR anywhere in such regions all have identical sequences. Thus, although sequencing-based analysis enables pinpointing breakpoints to one of these identical stretches-providing the highest attainable breakpoint resolution for any recurrent event-in some cases, inferred breakpoint intervals will remain large because there are no additional informative markers to refine the region further.
Experimental design
Breakpoint mapping generally involves discovery and confirmation of a duplication or deletion, refinement of breakpoint locations and validation. Multiple approaches are available for completing each of these stages, and we consider several refinement strategies here. Although massively parallel sequencing is not the only technology that is applicable to breakpoint refinement for recurrent events, sequencing is ultimately required to obtain sequence-level resolution. Here we overview several breakpoint localization methods, offer suggestions regarding their application in different situations and diagram their relationships to one another in the context of discovery, refinement and validation (Fig. 1) .
Array CGH (Steps 1-3 and 9-10). A conventional first step in resolving breakpoints is performing array CGH by using a custom-designed, high-density oligonucleotide microarray with probes spanning the region of interest and extending beyond the hypothesized breakpoint locations. This analysis provides useful qualitative information about events of interest, confirming them, defining minimal affected regions and suggesting particular segmental duplications that are likely to harbor breakpoints. In a best-case scenario, initial array CGH will refine breakpoint locations to specific segmental duplications-probe crosshybridization generally prevents further narrowing breakpoint locations within the duplications. Given the higher resolution of the sequencing-based approaches outlined below, their ability to 23 , Nature Publishing Group.
Box 1 | Genome sequence and haplotype characterization
To apply sequencing-based components of this protocol, it is crucial to accurately identify SUNs that distinguish breakpoint-associated segmental duplications from one another. How can one tell whether breakpoint-associated sequences are accurate and complete in a reference genome? Unless sequence gaps exist in these regions, evaluating the reference genome with regard to these criteria is challenging. We have found a variety of strategies particularly useful for this purpose: (i) mapping end sequences from clones from large-insert genomic libraries to the reference genome and searching for discordances between mapping locations and the known insert size range 36, 37 ; (ii) performing fluorescent in situ hybridization experiments using probes targeting breakpoint regions and surrounding loci; and (iii) generating and comparing copy-number profiles across breakpoint regions for hundreds of individuals from populations around the globe using massively parallel WGS data 22 . Collectively, these analyses and experiments provide some insight into the variability and complexity of the particular breakpoint regions in question and inform the researcher on whether their further genomic characterization and high-quality sequencing are necessary to develop an alternate reference genome. In cases where the reference genome is inaccurate or incomplete, we recommend sequencing bacterial artificial chromosomes (BACs) from genomic libraries by using Sanger 24 or Pacific Biosciences technology 38 and assembling a contig for each distinct structural haplotype. BAC libraries from hydatidiform mole source material, containing a single haplotype and lacking allelic variation, are especially useful for high-identity duplications in the human genome 24 . High-quality sequence characterization of a particular set of breakpoint-associated regions with this approach takes from one to several months to complete. Nevertheless, this process is fundamental for accurate SUN identification and the eventual interpretation of sequencing data. Thus, genomic characterization is the starting point for any breakpoint refinement effort whenever the reference genome fails to provide accurate sequence data capturing the full diversity and complexity of breakpoint-associated loci.
assay several pairs of candidate breakpoint-associated segmental duplications in a single experiment and the high cost of custom array design, array CGH is not necessary for breakpoint mapping. However, array CGH provides orthogonal data that are often useful when validating results or when analyzing sequencing data fails to define clear breakpoint intervals.
Haplotype isolation (Steps 4-8).
One strategy to achieve breakpoint resolution begins with the generation of humanmouse somatic cell hybrids to physically isolate the chromosome harboring the duplication or deletion and, separately, its parental progenitor 14, 15, 27 . Isolation of these chromosomes in somatic cell hybrids simplifies breakpoint localization for any method because afterward confounding effects of unaffected homologs need not be considered. This strategy can be leveraged to perform an array CGH experiment comparing the affected and parental chromosomes or to simplify the analysis of sequencing data. For example, we determined that two distinct types of NAHR accounted for the three deletions that we observed in patients with the 17q21.31 microdeletion syndrome. We reached that conclusion on the basis of observing two distinct patterns of haplotype-specific array CGH data 14 . With regard to sequencing data analysis, SUNs can be assessed for the presence or absence rather than relative read-depth when the input library is derived from any chromosome in isolation from its homolog.
Isolation of at least the affected chromosome is, therefore, in theory an optimal early step in any breakpoint mapping effort. However, we recognize that generating somatic cell hybrids is a time-consuming, expensive and highly specialized process, demanding specific expertise and experience, and it is not amenable to large-scale application. Therefore, haplotype isolation-based breakpoint resolution has been applied only for small numbers of cases in which the benefits described above promise considerable improvement in the quality of the results obtained over other options not requiring haplotype isolation. An emerging alternative to creating somatic cell hybrids for achieving haplotype isolation with greater efficiency is subhaploid complexity reduction and sequencing, for instance, with fosmids or in vitro dilution 28, 29 .
Any current haplotype isolation method remains very expensive and time-consuming relative to sequencing, and thus we recommend pursuing such a strategy only if WGS or targeted sequencing after one of the approaches described below fails to define breakpoint intervals. In such cases, haplotype isolation may prove worthwhile, particularly if the individual is homozygous for the structural haplotype on which the event occurred and if the breakpoint-associated segmental duplications have many paralogs throughout the genome-situations that are more challenging than those that we faced in the 17q21.31 study and our RH gene family example. Note that a failure of the sequencing-based approaches could indicate inaccuracy of the genomic sequences used for SUN identification, or their irrelevance in that particular case owing to NAHR having occurred on a structural haplotype distinct from those sequences, with accordingly different SUNs (Box 1).
As noted above, performing array CGH or haplotype-specific array CGH would probably yield some biological insight when sequencing strategies fail, particularly if array data can be generated for both unresolved and resolved cases involving the same genomic region and compared in a manner akin to our 17q21.31 analysis 14 .
WGS of a trio (Steps 11-20
). An alternative to haplotype isolation is high-coverage sequencing of diploid genomic DNA from the affected individual and both parents (a trio) and directly assaying sequence read-depth across the breakpointinformative regions to define the unequal crossover event 14 . Implementation of this approach enables the researcher to achieve sequence-level breakpoint resolution via bioinformatics analyses. Performing WGS provides a comprehensive view of genetic variation across the genome in addition to refined breakpoints, a feature that is particularly valuable in studies exploring genetic bases for variable expressivity of a recurrent event. One limitation of this strategy is its relatively high cost, which currently precludes its application to patient cohorts of even moderate size.
MIP capture and sequencing (Steps 21-103).
The majority of reads from sequencing libraries prepared from genomic DNA or even from an isolated affected chromosome are not useful for breakpoint refinement because they do not map to breakpoint regions or do not contain relevant SUNs. The approach described in this paragraph circumvents this problem by first enriching the sequencing library to obtain high coverage precisely over the regions that are most informative for breakpoint delineation 23 . Targeted capture using MIPs is particularly well suited for this purpose, as ~3,000 MIPs can be combined in a single reaction to simultaneously assay many loci [30] [31] [32] . MIPs are short oligonucleotides (70-80 bp) used to capture specific genomic targets <200 bp in length. They have been successfully applied to routinely genotype thousands of samples and are generally cost-effective compared with WGS when used to assay moderate to large numbers of samples.
Despite its advantages, MIP capture is not always preferable to WGS for breakpoint resolution. Not all SUNs are targetable using MIPs. Regions of particularly low or high GC content (<30% or >60%) are often refractory to successful capture 30, 31 , and high-copy repeats cannot be specifically targeted. As currently implemented, analysis of WGS data focuses on absolute readdepth over SUNs, whereas MIP sequence data analysis considers read-depth over SUNs relative to that over captured paralogous targets. This relative analytical framework makes regions of high aggregate copy number difficult to accurately analyze by the MIP method 23 . Furthermore, because such regions often contain very few SUNs, successfully interrogating as many individual SUNs as possible is crucial for breakpoint resolution within these regions. WGS, in principle, yields data for all SUNs, including those that MIPs would not capture. In general, however, we believe that MIPbased breakpoint resolution will prove more broadly useful than its counterpart based on WGS, at least until the cost of the latter approach becomes less prohibitive. proceDure targeted array cGH • tIMInG 2-3 d (plus the time it takes to receive microarrays)  crItIcal Many steps in the PROCEDURE specify using a centrifuge or a microcentrifuge to 'spin down' a sample (contained in plates or tubes), but they do not provide information regarding the centrifugation speed, duration and temperature. For these steps, the exact centrifugation speed, duration and temperature do not matter, so long as the centrifugation effectively ensures that all liquids in plates or tubes collect at the bottom of the wells or tubes.  crItIcal The implementation of this subsection of the PROCEDURE (Steps 1-3) is optional (see Experimental design for a relevant discussion on its suggested implementation). 1| Design a custom oligonucleotide microarray covering the region of interest by using the Agilent eArray design suite (http://www.genomics.agilent.com/en/product.jsp?cid=AG-PT-122&tabId=AG-PR-1047&_requestid=1207000). Probes should be 60 bp in length, and they should be designed at a high density over the target region (approximately one probe every 900 bp). To ensure adequate coverage of the region of interest, probe design should cover a larger region including at least 25 kb of flanking sequence on each side of the breakpoint-associated segmental duplications. The final probe set should include a substantial fraction of probes targeting unique regions outside of the region of interest (e.g., a genomic backbone), as such regions facilitate calibration of diploid state (see Step 3 below). Order the oligonucleotide arrays.  pause poInt Ordered custom oligonucleotide arrays take several weeks to months to arrive.
2|
Perform array CGH experiments using a sample from the individual whose DNA has the duplication or deletion under investigation and a sample from an individual whose DNA does not to approximate regions where breakpoints occur. Provided that DNA from the affected individual and both parents is available in sufficient quantity for these experiments (250 ng per individual per hybridization) and desired follow-up experiments, we recommend performing three separate array CGH experiments (comparing the affected individual to the mother, the affected individual to the father and the mother to the father). A protocol detailing the array CGH procedure has been previously published 16 .
3|
Analyze the array CGH data with the Agilent feature extraction software (http://www.genomics.agilent.com/en/ Microarray-Scanner-Processing-Hardware/Feature-Extraction-Software/?cid=AG-PT-144&tabId=AG-PR-1050) and custom analysis programs to generate plots of log 2 fluorescence intensity ratios across the spatial extent of the targeted region. For quality control, we recommend following the manufacturer's instructions, ensuring that the derivative log ratio spread is <0.23 per sample. To highlight probes signaling a deletion or a duplication, use different colors to visualize points with log 2 ratios of >1.5 s.d. from the mean log 2 ratio in the experiment. If probes in the region of interest constitute a substantial fraction of the total probe set (>5%), exclude these probes when calculating the mean and s.d. of log 2 ratios. Note that the signals from deletions and duplications affecting duplicated sequences will not be as strong as those observed for such events affecting unique sequences because the relative loss or gain of DNA is smaller for the sequences originally present at higher copy numbers.
Isolation of the affected chromosome and its parental progenitor(s)
• tIMInG 2-3 months  crItIcal The implementation of this subsection of the PROCEDURE (Steps 4-8) is optional (see Experimental design for a relevant discussion on the merits of implementing it). 4| Genotype DNA from the affected individual, as well as from both parents, using microsatellite markers (Marshfield map 34 ) along the chromosome of interest, including multiple markers in proximity to the deletion or duplication locus (within ~5 Mb). The Marshfield map is a collection of short-tandem repeat markers developed in the 1990s to map human genetic traits, integrate physical mapping data and assess patterns of recombination 34 . Obtaining genotypes at these markers will enable the experimenter to infer the haplotypes of the affected individual and of both parents. A protocol detailing microsatellite genotyping has been previously published 33 .
5| Generate human-mouse somatic cell hybrids, using standard materials and protocols, by performing electrofusion of human Epstein-Barr virus-transformed lymphoblast cells with mouse E2 cells and expanding transformants for 18 d.
The specific protocol that we use is described by Highsmith et al. 15 . Please note that the materials and equipment necessary to implement this step are also reported in the study by Highsmith et al. 15 .
6| Genotype the somatic cell hybrid colonies (50-100) for the same microsatellite markers as above, according to published protocols 15, 33 . Generating somatic cell hybrids yields several colonies, most of which do not contain the affected chromosome or a parental homolog in isolation. Genotyping microsatellites from several colonies enables the experimenter to identify these colonies of interest, and it provides insight into the integrity of the affected and parental homologous chromosomes that they contain.
7|
Genotype a denser panel of microsatellite markers, including several in close proximity (~1 Mb) to the deletion or duplication event, using DNA from a single colony that has the affected chromosome intact and in isolation and from four single colonies each having one parental homolog intact and in isolation. Follow the same published protocols as above 15, 33 .
The genotyping results will provide insight into the specific parental chromosome or chromosomes involved in the NAHR event, recombination patterns and the timing of the NAHR event in meiosis (i.e., meiosis I or II).
8| Propagate a single colony harboring the intact, isolated affected chromosome and a single colony harboring the intact, isolated parental homolog involved in NAHR (determined in the previous step). If two parental homologs were involved in the deletion or duplication event (i.e., NAHR was interchromosomal rather than interchromatidal), propagate at least three single colonies, one harboring each intact, isolated parental homolog involved in NAHR and one harboring the intact, isolated affected chromosome. Follow the published protocol 15 to propagate relevant colonies, and isolate DNA from each colony that can be used for haplotype-specific array CGH or sequencing experiments.
Haplotype-specific array cGH • tIMInG 2-3 d  crItIcal The implementation of this subsection of the PROCEDURE (Steps 9-10) is optional, but Steps 9 and 10 can only be performed after the completion of Steps 4-8 (see Experimental design for details and discussion).
9| Implement Steps 1-3 described above by using DNA from one expanded somatic cell hybrid colony harboring the affected chromosome as test and another harboring its progenitor as reference to obtain log 2 fluorescence intensity ratios. Provided that NAHR was interchromatidal in origin (the most typical case), this experiment allows for the direct comparison of the affected chromosome with an effectively isogenic background over the region of interest. This comparison is possible because the rearranged chromosome differs from the parental donor chromosome primarily as a result of the duplication or deletion event.
10| Assuming a model of NAHR, identify all directly orientated segmental duplications by using the 'segmental duplications' track on the University of California Santa Cruz (UCSC) Genome Browser (http://www.genome.ucsc.edu/) or the whole-genome assembly comparison pipeline 3 , if sequences of interest are not accurate or complete in the reference genome (Box 1). This pipeline defines all segmental duplications over 1 kb in length and having >90% sequence identity in a genome. For all duplication pairs, analyze log 2 ratio patterns over the spatial extent of the targeted region 14 . Comparing the observed log 2 ratios with expected log 2 ratios under different hypothesized NAHR scenarios enables the experimenter to define candidate breakpoint-harboring duplication pairs and eliminate others from consideration.
Massively parallel WGs and sunK analysis • tIMInG variable; 1-3 weeks, depending on the sequencing platform  crItIcal Please note that the implementation of this subsection of the PROCEDURE (Steps 11-20) is an alternative to the MIP-based approach (Steps 21-103, see Experimental design for relevant discussion).
11| Sequence libraries prepared from genomic DNA or haplotype-resolved chromosomes from the affected individual and both parents on an Illumina HiSeq according to the manufacturer's instructions and specifications detailed above (see WGS under Equipment Setup). Please note that sequencing will take anywhere from ~1 d to multiple weeks to complete, depending on the platform used. Once the sequencing run is complete, data should be stored and backed up before beginning the analysis. Please note as well that the first few steps of the analysis (Steps 12-15 below) do not require the sequencing data and can be completed while you are waiting for the sequencing run to finish.
12|
Obtain paralogous breakpoint-associated sequences and align them using an alignment program such as ClustalW2 (http://www.clustal.org/clustal2/). Make two fasta files from the alignment output, one containing the first aligned sequence and the other containing the second aligned sequence. These fasta files should include '-' characters within the nucleotide sequences at positions corresponding to alignment gaps. Both unaligned and aligned breakpoint-associated sequences must start with the first base in the alignment and end with the last base in the alignment. Name the unaligned sequences 'prox.fasta' and 'dist.fasta' (corresponding to the proximal and distal breakpoint-associated segmental duplications mediating the rearrangement) and the aligned sequences 'prox_aligned.fasta' and 'dist_aligned.fasta' . Make sure that the names of the sequences correspond to the file names (e.g., the file 'prox.fasta' should have '>prox' as its first line). Save all sequences in the same directory and name this directory 'brkpt_WGS', henceforth referred to as the project directory.
13|
Determine the reference sequence coordinates corresponding to the contig sequences-specifically, the reference coordinates of the first and last bases in the 'prox.fasta' and 'dist.fasta' files. Create a tab-delimited text file in the project directory detailing this information, with the chromosome name (i.e., 'chr1') in the first column, the base-1 start coordinate in the second column and the base-1 end coordinate in the third column. Name this file 'seqs.refcoords' . These regions must be listed in order of their reference genomic coordinates.
14|
Identify breakpoint-informative SUNKs (36 bp) and SUNs by running the script 'wgs_analysis_pt1.sh' from the project directory on a high-memory machine. This program will generate the text files 'brkpt.suns', 'brkpt.sunks' and 'brkpt.sunsunks' . It requires high memory (for an example test run, the 'top' command showed that VIRT was 52.0g and RES was 27g) to run and takes several hours to finish; we thus recommend running it overnight. Please note that the following Step 15 can be completed before this step finishes and before the sequencing run is complete.
$ bash $BRKPT_SOFTWARE/wgs_analysis_pt1.sh
? trouBlesHootInG
15|
Create a tab-delimited file listing the names of all samples pooled in the sequencing run in the first column and their corresponding barcode reverse complement sequences in the second column. Name this file 'brkpt.barcodekey' and save it in the project directory.
16|
After the sequencing run has completed, follow the manufacturer's instructions regarding bcl conversion to convert raw sequencing base call data to qseq text files. Make a new directory in the project directory called 'raw_qseq_files' and store the qseq text files in this new directory. Do not compress these files: running the script in the next step will do that.
17|
Change into the 'raw_qseq_files' directory and run the script 'wgs_analysis_pt2.sh' to generate gzipped fastq files that will be searched for breakpoint-informative SUNKs. These files will be generated in the 'raw_qseq_files' directory and moved to a directory within the parent directory called 'fastqs' .
$ cd raw_qseq_files $ bash $BRKPT_SOFTWARE/wgs_analysis_pt2.sh 18| Quantify read-depth over breakpoint-informative SUNs by running the script 'wgs_analysis_pt3.sh' from the 'raw_qseq_files' directory. Directories for each sample in the 'brkpt.barcodekey' file will be created within the 'fastqs' directory. In each of these sample directories, the final output is written to the file 'brkpt.suns.depth', with the last column of this file showing the observed read depth over each breakpoint-informative SUN.
$ bash $BRKPT_SOFTWARE/wgs_analysis_pt3.sh
19|
Analyze and visualize the data in R. To view data for a single individual, copy that individual's 'brkpt.suns.depth' file and the '$BRKPT_SOFTWARE/pdf_brkpt_WGS.r' file to a directory that R can access; open R and set the R working directory to that directory. Next, run the following commands in the R console to generate a file with a name like 'sample_brkpt.pdf', written to that directory. Replace 'sample' in the first command below with the name of the individual:
> indiv<-"sample" > source("pdf_brkpt_WGS.r")
20|
Manually inspect the pdf file with a name like 'sample_brkpt.pdf' showing read-depth data over breakpoint-informative SUNs for the individual of interest. Breakpoint signatures should be apparent as a decrease or increase of paralog-specific read-depth over the extent of the deletion or duplication (e.g., Fig. 2c ; see ANTICIPATED RESULTS for further discussion).
MIp design • tIMInG 1 d, plus 1-2 weeks to receive oligonucleotides  crItIcal As mentioned above, Steps 21-103 below should be performed as an alternative to the WGS approach (Steps 11-20, see Experimental design for relevant discussion).
21|
Obtain paralogous breakpoint-associated sequences and align them using an alignment program such as ClustalW2 (http://www.clustal.org/clustal2/). Make two fasta files from the alignment output, one containing the first aligned sequence and the other containing the second aligned sequence. These fasta files should include '-' characters within the nucleotide sequences at positions corresponding to alignment gaps. Both unaligned and aligned breakpoint-associated sequences must start with the first base in the alignment and end with the last base in the alignment. Name the unaligned sequences 'prox.fasta' and 'dist.fasta' (corresponding to the proximal and distal breakpoint-associated segmental duplications mediating the rearrangement) and the aligned sequences 'prox_aligned.fasta' and 'dist_aligned.fasta' . Make sure that the names of the sequences correspond to the file names (e.g., the file 'prox.fasta' should have '>prox' as its first line). Save all sequences in the same directory and name this directory 'brkpt_MIPs', henceforth referred to as the project directory.
22|
Generate initial MIP designs. The script 'mip_design_pt1.sh' calls several programs to design an initial set of MIPs targeting breakpoint-informative SUNs, detailed in the output file 'brkpt.mipdesign' . It typically takes 30 min-2 h to run. Run this script from the project directory:
$ bash $BRKPT_SOFTWARE/mip_design_pt1.sh 23| Import data from the tab-delimited text file 'brkpt.mipdesign' into Microsoft Excel, so that each column in the file is imported into a separate column in the spreadsheet and the data begin in position A1. The first line of the file 'prox.mipdesign' details the meaning of the data in each of the columns except for the last column, which contains the oligo sequences for all MIPs initially designed.
24| Sort the Excel spreadsheet by column S and delete all rows having a value in column S that includes 'snp' . This action will ensure that all remaining MIP designs have hybridization arms targeting sequences that are identical between both breakpoint-associated sequences.
25| Sort the Excel spreadsheet by column G, which contains the total number of copies of the extension hybridization arm sequence found in the human genome. Delete all rows having values in this column greater than a threshold cutoff. The exact value of this cutoff will differ on a case-by-case basis, but a good general rule to follow is that the cutoff should be approximately two times the number of copies of breakpoint-associated duplicated sequences in the haploid genome of interest. For example, if the breakpoint-associated sequences have no paralogous sequences elsewhere in the genome, this cutoff should be set to around 4. Increasing this cutoff will increase the number of MIPs designed and potentially the spatial resolution of refined breakpoints, but it may result in more off-target MIP capture events. Columns L-M contain the alignment coordinates of regions targeted by the remaining MIPs, so sorting by column L and examining the values in columns L-M in comparison with the length of the aligned sequence 'prox_aligned.fasta' provides some sense of the spatial resolution afforded by the remaining MIPs.
26| Sort the Excel spreadsheet by column K, which contains the total number of copies of the ligation hybridization arm sequence found in the human genome, and then delete all rows having values in the column greater than the same threshold cutoff imposed in Step 25.
27| Sort the Excel spreadsheet by column L to order the remaining MIPs by the alignment coordinates of the regions that they target. Copy all sequences in column N, paste them into a new text file named 'target.seqs' created in the project directory by using a command-line text editor such as vim (http://www.vim.org/) and save the text file. Next, run the following command from the project directory to calculate GC content for all remaining MIP target regions. This information will be taken into account by a later program that selects a set of MIPs that have good potential for successfully capturing targets harboring breakpoint-informative SUNs:
$ $BRKPT_SOFTWARE/calculate_target_GC target.seqs > target.gc 28| Import data from the text file 'target.gc' into column X of the Excel worksheet such that the data begin in position X1. Cut the data from column X and paste them to the same rows in column S. Copy all data in the spreadsheet, paste them into a new text file named 'brkpt.filtered.mipdesign' created in the project directory by using a command-line text editor such as vim (http://www.vim.org/) and save the text file. Next, run the script 'mip_design_pt2.sh' from the project directory to generate a file containing the final MIP oligos to order:
$ bash $BRKPT_SOFTWARE/mip_design_pt2.sh 29| Order MIPs (see Reagent Setup for order specifications). The final set of MIP oligonucleotides to order is specified in the last column of the file 'brkpt.filtered.mippicks' in the project directory.  pause poInt Ordered MIPs typically take 1-2 weeks to arrive.
MIp pooling and 5′ phosphorylation • tIMInG 2-3 h 30|
On the same day that the ordered MIPs are received in plates, allow these plates to thaw in a refrigerator at 4 °C .
31|
Remove thawed MIP plates from the refrigerator (maintained at 4 °C), and spin them down in a centrifuge.
32|
For each MIP plate, pool 5 µl of each MIP into a 1.7-ml Eppendorf tube. This pooling can be easily accomplished with an eight-channel 0.5-10-µl mechanical pipette to first pool MIPs from each row of a plate into an eight-tube strip of 200-µl PCR tubes and then pooling the contents of each PCR tube into an Eppendorf tube.
33| Pool together the MIP pools for each plate by combining P µl of each plate pool into a new 1.7-ml Eppendorf tube, where P = 0.1 times the number of MIPs in each plate pool, calculated separately for each plate pool.
34|
Add B µl of 10× T4 DNA ligase buffer with 10 mM ATP and K µl of T4 polynucleotide kinase to the same 1.7-ml tube containing the final MIP pool from Step 33. Here B = (5/26) × (volume of MIPs in that pool) and K = (7/26) × (volume of MIPs in that pool).
35|
If the total volume in the 1.7-ml tube after
Step 34 is <50 µl, add enough nuclease-free water to bring the final volume to 50 µl, then vortex the tube, spin it down in a microcentrifuge and then transfer the tube contents to a 200-µl PCR tube. Otherwise, use enough nuclease-free water to bring the final volume up to V µl, where V is the smallest multiple of 50 above the current total volume; vortex the mixture, centrifuge it as detailed above and then split up the final volume into multiple 200-µl PCR tubes, each containing 50 µl of solution. 39| Calculate the volume of MIP stock that should be added per MIP capture reaction. 1 ng of genomic DNA contains ~330 haploid genome copies. 200 ng of genomic DNA will be used per reaction; therefore, ~66,000 haploid genome copies will be present per reaction. Each MIP should be present at a ratio of 800 copies per haploid genome copy, so ~52,800,000 copies of each MIP are needed per reaction, or 8.8 × 10 −5 pmol. Thus, you will need to add M µl of MIP stock per reaction, where M = 8.8 × 10 −5 /C, and C = the concentration in µM calculated in Step 38. Because the value of M is typically very low, it is likely to be necessary to dilute the phosphorylated MIP stock with elution buffer to form a working stock solution and recalculate M on the basis of the concentration of the working stock. M should ideally be between 0.1 and 1 µl.
40|
Dilute genomic DNA samples to be analyzed to the same concentration S, which should be between 10 and 25 ng/µl.
41|
Label an Eppendorf plate with information about the experiment and add U µl of samples from
Step 40 to it, where U = 200/S, and S is the concentration of each sample from Step 40. Make sure to record the contents of each well for future reference.
42|
Remove two 96-well cold blocks from a freezer maintained at -20 °C.
43| Make a working stock of 0.25 mM dNTPs by combining 1 µl of 10 mM dNTP mix with 39 µl of nuclease-free water.
44| Set up a master mix for the MIP capture reactions in a 2-ml Eppendorf tube, keeping the tube and its contents on ice when not adding components. In addition to the DNA to be analyzed, each reaction mixture contains 2. Step 46), to transfer the master mix first to eight-well 200-µl PCR tubes so that the eight-channel 5-100-µl pipette can be used to add the master mix to the plate with samples.
45|
Place the labeled plate with samples into a 96-well cold block.
46|
Vortex the master mix, spin it down in a microcentrifuge and add MM µl of the master mix to each well of the plate with samples, where MM = 25-U, and U is the volume of sample added per well determined in Step 41. We recommend first transferring the master mix to eight-well 200-µl PCR tubes (placed in the remaining 96-well cold block) so that the eight-channel 5-to 100-µl pipette can be used to add the master mix to the plate. Mix the master mix with the samples by pipetting up and down a few times with the tips in the wells.
47|
Seal the plate with a PCR plate seal.  crItIcal step The plate must be sealed very well, particularly along the edges, or some samples will probably evaporate during the capture reaction.
48|
Spin down the plate in a centrifuge.
49|
Incubate the sealed plate in a thermocycler for ~23 h. Set the thermocycler to run at 95 °C for 10 min, followed by 60 °C indefinitely, with a heated lid at 105 °C. Do not place the tubes in the thermocycler until the block temperature reaches 95 °C.
exonuclease treatment • tIMInG ~1 h 50| When the capture reactions from
Step 49 have nearly completed (~22.5 h after they were placed in the thermocycler), remove the Ampligase buffer from the freezer (-20 °C) and allow it to thaw completely.
51| After the capture reactions from
Step 49 have been completed (~23 h after they were placed in the thermocycler), remove two 96-well cold blocks from the freezer (-20 °C) and allow them to thaw for ~5 min.
52|
Remove the plate from the thermocycler, place it into a 96-well cold block and spin it down in a centrifuge.
53|
Set up a master mix for the exonuclease reactions in a 1.7-ml Eppendorf tube, keeping the tube and its contents on ice when not adding components. In addition to the capture reaction products, each reaction contains 0.5 µl of exonuclease I, 0.5 µl of exonuclease III, 0.2 µl of Ampligase buffer and 0.8 µl of nuclease-free water. Make enough master mix to allow for pipetting error, particularly if you are planning to transfer the master mix first to eight-well 200-µl PCR strip tubes, so that the eight-channel 0.5-10-µl pipette can be used to add the master mix to the plate with samples (recommended).
54|
Vortex the master mix, spin it down in the microcentrifuge and add 2 µl of the master mix to each well of the plate with capture reactions. We recommend first transferring the master mix to eight-well 200-µl PCR strip tubes (placed in the remaining 96-well cold block) so that the eight-channel 0.5-10-µl pipette can be used to add the master mix to the plate. Mix the master mix with the capture reactions by pipetting up and down a few times with the tips in the wells.
55|
Seal the plate with a PCR plate seal.
56| Spin down the plate in a centrifuge.
57|
Incubate the sealed plate in a thermocycler. Set the thermocycler to run at 37 °C for 45 min, followed by 95 °C for 2 min and then 4 °C indefinitely, with a heated lid at 105 °C. Do not place the tubes in the thermocycler until the block temperature reaches 37 °C.  pause poInt Exonuclease-treated capture reactions can be stored at 4 °C for several days. Nevertheless, we recommend proceeding to quantitative PCR within a day of finishing the exonuclease treatment.
Quantitative pcr • tIMInG ~1 h 58| After the reactions from Step 57 have been completed (the 4 °C stage has been reached in the thermocycler), remove the plate from the thermocycler and spin it down in a centrifuge.
59|
Remove a 96-well cold block from the freezer (-20 °C).
60|
Remove the reverse barcode primer plate (see Reagent Setup) from the refrigerator (4 °C) and spin it down in a centrifuge.
61|
Set up a master mix for eight (or as many samples are being analyzed plus one, if fewer than seven samples are being analyzed) quantitative PCRs in a 1.7-ml Eppendorf tube, keeping the tube and its contents on ice when not adding components. In addition to exonuclease reaction products and reverse primers to be added separately, each reaction contains 12.5 µl of 2× iProof PCR master mix, 0.125 µl of forward primer solution (SLXA_PE_MIPBC_FOR, 100 µM; supplementary table 1), 0.125 µl of SYBR Green 100× and 6 µl of nuclease-free water. Prepare enough master mix to allow for pipetting error.
62| Put one strip of eight-well optical PCR tubes in the cold block, vortex the master mix, spin it down in a microcentrifuge and add 18.75 µl of master mix to each optical PCR tube.
63|
Add 5 µl of exonuclease reaction products from the first column of the exonuclease reaction plate, except for the last row, to the eight-well optical PCR tubes with the eight-channel 0.5-10-µl pipette. Mix the exonuclease reaction products with the master mix by pipetting up and down a few times with the tips in the wells. Add 5 µl of nuclease-free water to the optical PCR tube without added exonuclease reaction product to serve as a negative control, and then mix by pipetting up and down a few times with the tip in the well. 
65|
Seal the eight-well optical PCR tubes using an eight-cap strip of optical qPCR caps and spin them down in a microcentrifuge.
66|
Incubate the sealed plate in a light thermocycler. Set the light thermocycler to run at 98 °C for 30 s, followed by 30 cycles at 98 °C for 10 s, 60 °C for 30 s, 72 °C for 20 s, a plate read and 72 °C for 10 s, followed by 72 °C for 2 min and then 4 °C indefinitely, with a heated lid at 105 °C. Do not place the tubes in the thermocycler until the block temperature reaches 98 °C.
67|
Determine approximately how many cycles (Y) the quantitative PCRs took until the fluorescence curves reached their plateaus by manually inspecting the fluorescence curves. Also ensure that this value was tightly distributed between individual curves (the highest value should be within two cycles of the lowest value, excluding the value corresponding to the negative control curve, which should plateau far later than all other curves or not plateau at all). Typical values for Y are in the 17-24-cycle range, depending on the MIP pool used and the initial amount of DNA added to each MIP capture reaction. ? trouBlesHootInG pcr • tIMInG ~1 h 68| Remove two 96-well cold blocks from the freezer (-20 °C).
69|
Remove the reverse barcode primer plate from the refrigerator (4 °C) and spin it down in a centrifuge.
70|
Set up a master mix for the PCRs in a 15-ml Falcon tube, keeping the tube and its contents on ice when not adding components. In addition to exonuclease reaction products and reverse primers to be added separately, each reaction contains 12.5 µl of 2× iProof PCR master mix, 0.125 µl of forward primer (SLXA_PE_MIPBC_FOR, 100 µM; supplementary table 1) and 6.125 µl of nuclease-free water. Make enough master mix to allow for pipetting error, particularly if you are planning to transfer the master mix first to eight-well 200 µl-PCR tubes so that the eight-channel 5-100-µl pipette can be used to add the master mix to the plate with samples (recommended).
88| Add fresh 70% (vol/vol) ethanol to the tube in the magnet tube rack such that the beads are fully covered (1 ml usually works well) and incubate the tube for 30 s.
89|
Taking care not to disturb the beads, while keeping the Eppendorf tube in the magnet tube rack, pipette the 70% (vol/vol) ethanol and discard it into an empty 100-ml beaker.
90|
Allow the beads to air-dry for 5 min.
91|
Remove the tube with beads from the magnet tube rack and add to it 100 µl of elution buffer, making sure to bring the beads into solution.
92|
Mix the tube contents well by pipetting up and down at least ten times.
93|
Place the tube with the beads in elution buffer back into the magnet tube rack and wait for 1 min.
94|
Taking care not to disturb the beads, while keeping the Eppendorf tube in the magnet tube rack, pipette out the elution buffer (which now contains cleaned-up DNA from the PCRs) and transfer it to a new 1.7-ml Eppendorf tube. Label the tube with details regarding its contents. This tube contains the final library for sequencing (to be performed in Step 96).  pause poInt Cleaned, pooled PCR products can be stored at 4 °C for months or at -20 °C indefinitely.
size confirmation by gel electrophoresis • tIMInG 15 min-2 h 95| Run 4 µl of the final library for sequencing on a gel by using the eGel system or by manually setting up an electrophoresis experiment with an agarose gel (1-2% (wt/vol)). Ensure that only a single major band of ~274 bp, corresponding to the desired MIP PCR products, is present. Step 94 and the sequencing primers. We recommend measuring concentration with the Qubit dsDNA HS assay (included with the Qubit DNA quantification system). Please note that sequencing will take from ~1 d to multiple weeks to complete, depending on the platform used. Once the sequencing run is complete, store and back up data before beginning the analysis. The first step of the analysis (Step 97) does not require the sequencing data and can be completed while waiting for the sequencing run to finish.
Data analysis • tIMInG ~3 h 97|
Create a tab-delimited file listing the names of all samples pooled in the sequencing run in the first column and their corresponding reverse barcode primer reverse complement sequences in the second column. Name this file 'brkpt.barcodekey' and save it in the project directory.
98|
99|
Change into the new directory and run the script 'mip_analysis_pt1.sh' to generate gzipped fastq files that will be used for mapping. These files will be generated in the 'raw_qseq_files' directory and moved to a directory within the parent directory called 'mrfast_mapping_input' .
$ cd raw_qseq_files $ bash $BRKPT_SOFTWARE/mip_analysis_pt1.sh 100| Map reads with mrFAST 35 to a custom genome, consisting of chromosomes 'prox' and 'dist' containing the sequences in 'prox.fasta' and 'dist.fasta', respectively. Refer to the mrFAST user manual for detailed mapping instructions. Use the parameters '--pe --max 160 --min 144 -e 4 --discordant-vh --seqcomp --outcomp --maxoea 500' . Gzipped input fastq files can be found in the 'mrfast_mapping_input' directory in the project directory, and mapping output files should be written to the 'mrfast_mapping_output' directory in the project directory. Perform the cleanup steps again using a smaller ratio than 1.8 (as low as 0.6) for the volume of magnetic beads added per microliter of pooled PCR product. Perform size confirmation by gel electrophoresis to ensure that having followed the modified cleanup protocol effectively removed the smaller band from the final library for sequencing
Steps 78-94, cleanup: 30 min
Step 95, size confirmation by gel electrophoresis: 15 min-2 h
Step 96, massively parallel sequencing: variable; ~1 d-3 weeks, depending on the sequencing platform Steps 97-103, data analysis: ~3 h
antIcIpateD results
The end product of WGS or MIP-based analysis as detailed in the present protocol should be a copy-number profile corresponding to paralog-specific read-depth over informative SUNs that distinguish the two segmental duplications that were involved in an unequal crossover event (NAHR). WGS analysis will yield plots resembling those reported in Figure 3 .
The plot for an individual where an unequal crossover event has occurred should reveal a transition in paralog-specific copy number over the spatial extent of aligned breakpoint-associated sequences (e.g., Fig. 3b) . The region lacking breakpoint-informative SUNs where the transition in copy number occurs defines the boundary or the breakpoint interval. Perfect sequence identity between breakpoint-associated segmental duplications over this region prohibits the breakpoint interval from being refined any further. Notably, paralog-specific read-depths of zero will only be observed in a few specific cases: when individual chromosomal haplotypes have been isolated, or when the proband has a deletion and is heterozygous for the structural haplotype on which the deletion occurred. MIP analysis yields similar results to those obtained from WGS analysis, including a plot showing paralog-specific read-count frequencies on the y axis and the alignment coordinate on the x axis. As in the WGS analysis, the plots will show two patterns of paralog-specific relative read-depth over the spatial extent of aligned breakpoint-associated sequences, separated by a region lacking breakpoint-informative SUNs that defines the breakpoint interval. This plot will differ slightly from the example in Figure 4 in that it will show relative rather than absolute paralog-specific copy-number estimates, and it will use alignment coordinates rather than genomic coordinates.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
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